Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Mixed evidenceCoverage 5/5 core metricsLatest reported annual revenue changed -2.5% from the prior reported annual observation.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Revenue contracted
Latest reported annual revenue changed -2.5% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- Shareholders' equity was non-positive
Debt/equity is shown as not meaningful rather than as a negative leverage ratio.
Why this surfaced
Same-period reported shareholders' equity was zero or negative; review the balance sheet and capital structure. Period end 2025-12-31.
- 2 filing risk checks flagged
Flagged areas: Earnings quality, Dilution.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
- Operating margin improved
Operating margin changed +2.5 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
- Free cash flow was positive
Latest reported free cash flow was $30M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Earnings quality
- Dilution
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-10-21
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product Revenue$187Mshare n/a-2.8% yoy
- Pellet Procedures Product Revenue$137Mshare n/a-8.8% yoy
- Dietary Supplements$42.9Mshare n/a+19.1% yoy
- Service Revenue$5.29Mshare n/a+6.9% yoy
- Disposable Trocars Product Revenue$4.85Mshare n/a+11.7% yoy
- Other Service Revenue$2.86Mshare n/a+25.9% yoy
- Shipping Fees And Other Product Revenue$2.15Mshare n/a+38.9% yoy
- Contract Term Services Revenue$1.36Mshare n/a+11.1% yoy
- +1 more member in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$191M100.0%-2.5% yoy
Members sum to the consolidated $192M for this period.
- Product Revenue$43.4Mshare n/a-9.0% yoy
- Pellet Procedures Product Revenue$30.3Mshare n/a-13.9% yoy
- Dietary Supplements$11.4Mshare n/a+5.7% yoy
- Disposable Trocars Product Revenue$1.21Mshare n/a-1.5% yoy
- Service Revenue$851Kshare n/a-29.4% yoy
- Shipping Fees And Other Product Revenue$505Kshare n/a+6.5% yoy
- +3 more members in the filing
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,060 US-listed filers · 790 in Materials| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $192M | 33rdof 3,247 bottom third | 53rdof 512 middle third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | -2.5% | 23rdof 3,083 bottom third | 30thof 464 bottom third |
Operating margin operating income ÷ revenue | 18.5% | 83rdof 2,777 top third | 88thof 474 top third |
Net margin net income ÷ revenue | 14.1% | 78thof 3,212 top third | 85thof 508 top third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | 15.7% | 77thof 2,640 top third | 84thof 425 top third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 4.6% | 36thof 2,852 middle third | 58thof 466 middle third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 13 days | 87thof 2,373 top third | 89thof 382 top third |
Net debt ÷ operating cash flow net debt ÷ operating cash flow (OCF > 0) · lower is ranked higher | 2.2× | 49thof 1,524 middle third | 55thof 143 middle third |
Cash conversion operating cash flow ÷ net income (net income > 0) | 1.3× | 41stof 2,243 middle third | 42ndof 191 middle third |
Cash-flow accrual ratio (net income − operating cash flow) ÷ average total assets · lower is ranked higher | -7.1% | 62ndof 3,845 middle third | 52ndof 752 middle third |
Balance-sheet accrual ratio change in net operating assets ÷ average net operating assets · lower is ranked higher | -3412.2% | 100thof 3,301 top third | 100thof 662 top third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 22 changed periods| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Operating income OperatingIncomeLoss | quarter 2021-09-30 | -$289K 10-Q/A 2021-11-29 | $8.98M 10-Q/A 2023-03-29 | +3207.1% | first · latest · 3 filings carry it |
| Operating cash flow NetCashProvidedByUsedInOperatingActivities | fiscal year 2021-12-31 | -$1.37M 10-K 2022-04-07 | $33.7M 10-K 2023-03-29 | +2559.9% | first · latest |
| Operating cash flow NetCashProvidedByUsedInOperatingActivities | quarter 2022-03-31 | -$335K 10-Q 2022-05-23 | $6.97M 10-Q 2023-05-12 | +2180.1% | first · latest |
| Operating income OperatingIncomeLoss | quarter 2021-06-30 | -$503K 10-Q 2021-08-17 | $10.3M 10-Q/A 2023-03-29 | +2139.4% | first · latest · 3 filings carry it |
| Operating income OperatingIncomeLoss | fiscal year 2021-12-31 | -$3.32M 10-K 2022-04-07 | $34.6M 10-K 2023-03-29 | +1140.5% | first · latest |
| Operating income OperatingIncomeLoss | quarter 2022-03-31 | -$1.24M 10-Q 2022-05-23 | $9.76M 10-Q 2023-05-12 | +887.1% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2021-03-31 | $5M 10-Q 2021-05-20 | -$37.7M 10-Q 2022-05-23 | -853.7% | first · latest · 4 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2021-06-30 | $5M 10-Q 2021-08-17 | -$24.4M 10-Q/A 2021-11-29 | -589.0% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2021-12-31 | -$22.6M 10-K 2022-04-07 | $4.13M 10-K 2023-03-29 | +118.2% | first · latest · 7 filings carry it |
| Total liabilities Liabilities | balance at 2021-12-31 | $23.2M 10-K 2022-04-07 | $50.2M 10-K 2023-03-29 | +116.7% | first · latest · 7 filings carry it |
| Net income NetIncomeLoss | quarter 2022-06-30 | $115M 10-Q 2022-08-15 | -$2.61M 10-Q 2023-08-11 | -102.3% | first · latest · 3 filings carry it |
| Net income NetIncomeLoss | quarter 2024-03-31 | -$2.07M 10-Q 2024-05-10 | -$4.16M 10-Q 2025-05-09 | -101.0% | first · latest |
| Net income NetIncomeLoss | quarter 2022-09-30 | -$13.2M 10-Q 2022-11-14 | $15K 10-Q 2023-11-13 | +100.1% | first · latest · 3 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2022-06-30 | -$25M 10-Q 2022-08-15 | -$49.1M 10-Q/A 2023-03-29 | -97.0% | first · latest |
| Operating income OperatingIncomeLoss | quarter 2021-03-31 | -$1.07M 10-Q 2021-05-20 | -$108K 10-Q 2022-05-23 | +89.9% | first · latest |
| Diluted shares WeightedAverageNumberOfDilutedSharesOutstanding | quarter 2022-06-30 | 57,434,067 shares 10-Q 2022-08-15 | 7,574,271 shares 10-Q 2023-08-11 | -86.8% | first · latest · 3 filings carry it |
| Total assets Assets | balance at 2021-12-31 | $318M 10-K 2022-04-07 | $54.3M 10-K 2023-03-29 | -82.9% | first · latest · 7 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2022-09-30 | -$37.2M 10-Q 2022-11-14 | -$48.1M 10-Q/A 2023-03-29 | -29.4% | first · latest |
| Total liabilities Liabilities | balance at 2022-09-30 | $219M 10-Q 2022-11-14 | $180M 10-Q/A 2023-03-29 | -17.8% | first · latest |
| Total liabilities Liabilities | balance at 2022-06-30 | $219M 10-Q 2022-08-15 | $187M 10-Q/A 2023-03-29 | -14.7% | first · latest |
| Net income NetIncomeLoss | quarter 2024-06-30 | -$6.32M 10-Q 2024-08-09 | -$7.09M 10-Q 2025-08-08 | -12.1% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2024-03-31 | -$35.4M 10-Q 2024-05-10 | -$36M 10-Q 2025-05-09 | -1.8% | first · latest |
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
Not available for BTMD yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.